Management of Insomnia in Elderly Patients

First-Line Approach

The American College of Physicians recommends cognitive behavioral therapy for insomnia (CBT-I) as the first-line treatment for elderly patients with insomnia, with pharmacological options reserved for when CBT-I alone is unsuccessful 1, 2
CBT-I is the recommended initial intervention for chronic insomnia in elderly patients, showing improved global outcomes and sleep parameters with minimal side effects 1
CBT-I components include cognitive therapy, behavioral interventions (sleep restriction, stimulus control), and sleep hygiene education 1

Low-dose doxepin (3-6mg) is effective for sleep maintenance insomnia in older adults with moderate evidence showing improved Insomnia Severity Index scores 1, 3
Eszopiclone (1-2mg) can improve both sleep onset and maintenance in elderly patients, with lower doses (1mg) recommended for this population 1, 4
Zolpidem (5mg) may be used for sleep-onset insomnia in elderly patients, but should be used at reduced doses (5mg vs standard 10mg) due to increased risk of adverse effects 1, 4
Zaleplon (5mg) may be considered for sleep-onset insomnia in elderly patients, but should be used at reduced doses (5mg vs standard 10mg) 4
Administration of zaleplon on an empty stomach is advised to maximize effectiveness, and caution and downward dosage adjustment is advised in the elderly 4

The American Geriatrics Society recommends starting with the lowest available doses in elderly patients due to altered pharmacokinetics and increased sensitivity to side effects 5
The FDA recommends limiting the duration of pharmacological therapy to short-term use (4-5 weeks) 1
Monitoring for adverse effects, including next-day impairment, falls, fractures, confusion, and behavioral abnormalities, is crucial when using pharmacological interventions in elderly patients 1, 6